Us Bancorp \De\ Olema Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$10.95 - $16.62 $153 - $232	14 Added 9.79%	157 $1,000
Q4 2023 Feb 09, 2024	BUY	$10.53 - $17.14 $1,505 - $2,451	143 New	143 $2,000
Q1 2022 May 11, 2022	SELL	$3.89 - $9.43 $12,082 - $29,289	-3,106 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.75 - $30.71 $25,576 - $89,765	2,923 Added 1597.27%	3,106 $29,000
Q3 2021 Nov 10, 2021	SELL	$22.96 - $30.13 $2,640 - $3,464	-115 Reduced 38.59%	183 $5,000
Q2 2021 Aug 05, 2021	BUY	$21.15 - $36.14 $5,922 - $10,119	280 Added 1555.56%	298 $8,000
Q1 2021 Apr 28, 2021	BUY	$27.81 - $53.64 $500 - $965	18 New	18 $1,000

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $247M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.